Injections Fewer migraines. More life.
OnabotulinumtoxinA preventive therapy for chronic migraines, administered according to the FDA-approved PREEMPT protocol by a physician who treats migraine as the serious neurological condition it is.
Book an Appointment


















That Changes the Math
OnabotulinumtoxinA (Botox) is FDA-approved for the preventive treatment of chronic migraines in adults who experience 15 or more headache days per month, with at least eight of those being migraine days. The PREEMPT protocol, through which Botox is administered for chronic migraine, involves a specific pattern of 31 or more injections across seven head and neck muscle groups every 12 weeks. Clinical trials demonstrated a reduction of approximately eight to nine headache days per month compared to placebo.
At Superior Health Medical and Wellness, Dr. Akers offers Botox preventive therapy for chronic migraine patients as part of a comprehensive migraine management approach. She evaluates your migraine history, current medication regimen, and prior treatment responses to determine whether Botox preventive therapy is an appropriate addition to your care and coordinates with your neurologist when needed for complex cases.
Book Your Appointment
From PREEMPT protocol injections and migraine evaluation to headache tracking and combination preventive therapy, Dr. Akers provides comprehensive neurotoxin migraine care at Superior Health. Explore the services below.
a Disability. Treat It That Way.

Chronic migraine is classified as a disability by the World Health Organization. Fifteen or more headache days per month means that on average, every other day involves a headache. The cognitive impact, the lost workdays, the social isolation, and the anxiety about when the next attack will come profoundly affect quality of life in ways that extend far beyond the hours of the headache itself.
Multiple clinical trials have demonstrated that Botox reduces chronic migraine frequency by 50 percent or more in a significant proportion of patients. Unlike daily oral preventive medications, Botox requires treatment only every 12 weeks and does not require daily adherence or produce the daily side effects that cause many patients to discontinue oral preventives.
Patients with chronic migraine frequently overuse acute medications, including triptans and NSAIDs, which can themselves cause medication overuse headache and worsen the underlying migraine pattern. Effective preventive therapy that reduces migraine frequency also reduces the need for acute medications, breaking the medication overuse cycle and improving overall migraine control.
More Life.
Preventive neurotoxin therapy that interrupts the chronic migraine cycle at its neurological source, reducing frequency, severity, and duration month after month.
Book a Consultation
Migraines
The mechanism by which onabotulinumtoxinA prevents migraines is distinct from its cosmetic muscle-relaxing mechanism. In migraine prevention, Botox is thought to work by blocking the release of neuropeptides, particularly calcitonin gene-related peptide (CGRP) and substance P, from peripheral sensory nerve terminals in the scalp and head and neck muscles. These neuropeptides play a central role in the neurogenic inflammation cascade underlying migraine.
By reducing neuropeptide release from peripheral sensory fibers, Botox decreases the sensitization of the trigeminal pain pathway that underlies migraine. This is a fundamentally different mechanism than its effect on motor nerves, which is why patients on Botox for chronic migraine do not experience the muscle weakness in treated areas that would occur with equivalent doses used cosmetically.
The clinical effect builds over successive treatment cycles because the biological changes in peripheral sensitization and neuropeptide signaling accumulate with repeated treatment. This is why patients who discontinue after one cycle often see a return of migraines, while those who continue for three or more cycles frequently achieve much more durable and meaningful reduction in headache frequency.

for Chronic Migraine
Insurance coverage for Botox migraine prevention typically requires documentation of chronic migraine, defined as 15 or more headache days per month for at least three months, and documentation of at least two failed oral preventive medication trials. Dr. Akers helps compile the necessary documentation and works with your insurance to obtain authorization before the first treatment session.
Treatment sessions involve 31 or more injections across the head and neck and take approximately 20 minutes. Most patients find the injections comfortable and well-tolerated. Results from the first treatment cycle are often modest, with more significant improvement developing after the second and third cycles. Dr. Akers schedules your 12-week treatment cycles proactively and monitors your response at each visit.
Schedule Your Migraine Neurotoxin ConsultationAnswered

